. Author manuscript; available in PMC: 2013 Nov 1.

Published in final edited form as: Cancer Causes Control. 2012 Sep 8;23(11):1805–1810. doi: 10.1007/s10552-012-0059-y

Table 3b.

ABO diplotypes incorporating the A2 allele and risk of ovarian cancer in 7 studies from the Ovarian Cancer Association Consortium^a

Diplotype	Cases (N)	Controls (N)	OR	95% CI	p^b
O/O	1442	1948	1.00	(ref.)
A1/O	955	1155	1.17	(1.02–1.33)	0.02
A1/A1	153	201	1.07	(0.81–1.40)	0.65
A2/O	260	356	1.03	(0.86–1.23)	0.76
A2/A2	9	16	1.10	(0.43–2.79)	0.85
A1/A2	86	116	1.03	(0.72–1.46)	0.89
A1/B	106	150	1.02	(0.78–1.34)	0.88
A2/B	28	36	1.15	(0.67–1.97)	0.61
B/O	347	473	1.05	(0.87–1.27)	0.58
B/B	30	41	1.10	(0.66–1.85)	0.71

UKG was not included in this analysis.

Studies were combined using random effects meta-analysis; all p-heterogeneity between studies >0.20.